Natural Alternatives International (NAII) Competitors $2.72 +0.03 (+1.12%) Closing price 10/24/2025 03:58 PM EasternExtended Trading$2.72 -0.01 (-0.18%) As of 10/24/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. ALGS, ACRV, NRXP, CUE, OTLK, ANL, GNTA, MNOV, JATT, and BRNSShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Aligos Therapeutics (ALGS), Acrivon Therapeutics (ACRV), NRx Pharmaceuticals (NRXP), Cue Biopharma (CUE), Oncobiologics (OTLK), Adlai Nortye (ANL), Genenta Science (GNTA), MediciNova (MNOV), JATT Acquisition (JATT), and Barinthus Biotherapeutics (BRNS). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Its Competitors Aligos Therapeutics Acrivon Therapeutics NRx Pharmaceuticals Cue Biopharma Oncobiologics Adlai Nortye Genenta Science MediciNova JATT Acquisition Barinthus Biotherapeutics Natural Alternatives International (NASDAQ:NAII) and Aligos Therapeutics (NASDAQ:ALGS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Does the media favor NAII or ALGS? In the previous week, Aligos Therapeutics had 1 more articles in the media than Natural Alternatives International. MarketBeat recorded 4 mentions for Aligos Therapeutics and 3 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 1.92 beat Aligos Therapeutics' score of 0.77 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natural Alternatives International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Aligos Therapeutics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of NAII or ALGS? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 60.4% of Aligos Therapeutics shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by company insiders. Comparatively, 4.8% of Aligos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer NAII or ALGS? Aligos Therapeutics has a consensus target price of $50.00, suggesting a potential upside of 416.00%. Given Aligos Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Aligos Therapeutics is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Aligos Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings and valuation, NAII or ALGS? Natural Alternatives International has higher revenue and earnings than Aligos Therapeutics. Natural Alternatives International is trading at a lower price-to-earnings ratio than Aligos Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$129.86M0.13-$13.57M-$2.27-1.20Aligos Therapeutics$3.94M15.13-$131.21M-$19.79-0.49 Is NAII or ALGS more profitable? Natural Alternatives International has a net margin of -10.45% compared to Aligos Therapeutics' net margin of -2,337.24%. Natural Alternatives International's return on equity of -9.69% beat Aligos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-10.45% -9.69% -4.73% Aligos Therapeutics -2,337.24%-22.41%-12.09% Which has more volatility and risk, NAII or ALGS? Natural Alternatives International has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500. Comparatively, Aligos Therapeutics has a beta of 2.77, suggesting that its share price is 177% more volatile than the S&P 500. SummaryNatural Alternatives International and Aligos Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.83M$2.62B$6.21B$10.81BDividend YieldN/A57.77%5.72%4.80%P/E Ratio-1.2028.3731.6030.99Price / Sales0.13786.95595.06133.64Price / CashN/A168.8137.2561.86Price / Book0.255.6512.056.61Net Income-$13.57M$33.06M$3.34B$277.10M7 Day Performance3.42%3.16%1.94%2.57%1 Month Performance-5.56%7.06%6.88%3.20%1 Year Performance-43.33%-2.15%56.06%33.22% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International1.7038 of 5 stars$2.72+1.1%N/A-43.3%$16.83M$129.86M-1.20290News CoveragePositive NewsAnalyst ForecastHigh Trading VolumeALGSAligos Therapeutics4.0427 of 5 stars$10.49+0.5%$50.00+376.6%+15.4%$64.51M$3.94M-0.5390News CoverageAnalyst ForecastACRVAcrivon Therapeutics3.1557 of 5 stars$2.04+6.3%$15.00+635.3%-74.0%$64.17MN/A-0.9158Analyst ForecastNRXPNRx Pharmaceuticals2.7763 of 5 stars$3.21-3.0%$34.50+974.8%+160.3%$63.59MN/A-1.432Analyst ForecastGap UpCUECue Biopharma2.4421 of 5 stars$0.83+0.5%N/A-46.9%$63.40M$9.29M-1.4760Positive NewsGap UpOTLKOncobiologics2.8171 of 5 stars$1.41-4.7%$7.00+396.5%-74.4%$62.63MN/A-2.4720Positive NewsANLAdlai Nortye1.215 of 5 stars$1.66+0.3%$9.00+443.8%-20.6%$61.07M$5M0.00127Analyst ForecastShort Interest ↑Gap UpGNTAGenenta Science1.0912 of 5 stars$3.29+2.8%N/A+17.0%$60.17MN/A0.007News CoverageGap UpMNOVMediciNova2.4008 of 5 stars$1.22+0.8%$7.00+473.8%-24.5%$59.84M$134.60K-4.8810JATTJATT AcquisitionN/A$3.37+5.0%N/A-20.5%$58.13MN/A0.003Gap UpHigh Trading VolumeBRNSBarinthus Biotherapeutics2.6128 of 5 stars$1.39+1.2%$3.00+115.8%-10.7%$56.60M$14.97M-0.80107News CoverageShort Interest ↑ Related Companies and Tools Related Companies Aligos Therapeutics Competitors Acrivon Therapeutics Competitors NRx Pharmaceuticals Competitors Cue Biopharma Competitors Oncobiologics Competitors Adlai Nortye Competitors Genenta Science Competitors MediciNova Competitors JATT Acquisition Competitors Barinthus Biotherapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis gold stock is STILL undervalued by 80%...“Like buying gold for $1,000/oz” If you could go back in time to 10+ years ago and buy gold for $1,000 an o...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAII Stock Alerts